Feedback / Questions
namilumab (IZN-101) - Amgen, Izana Biosci, Roivant
http://clinicaltrials.gov/ct2/show/NCT05314517
Apr 25, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next